Cargando…
Anti-Diabetic Therapy and Heart Failure: Recent Advances in Clinical Evidence and Molecular Mechanism
Diabetic patients have a two- to four-fold increase in the risk of heart failure (HF), and the co-existence of diabetes and HF is associated with poor prognosis. In randomized clinical trials (RCTs), compelling evidence has demonstrated the beneficial effects of sodium-glucose co-transporter-2 inhib...
Autores principales: | Hsu, Chih-Neng, Hsuan, Chin-Feng, Liao, Daniel, Chang, Jack Keng-Jui, Chang, Allen Jiun-Wei, Hee, Siow-Wey, Lee, Hsiao-Lin, Teng, Sean I. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144651/ https://www.ncbi.nlm.nih.gov/pubmed/37109553 http://dx.doi.org/10.3390/life13041024 |
Ejemplares similares
-
Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice
por: Hsuan, Chin-Feng, et al.
Publicado: (2023) -
T helper 17 cells: A new actor on the stage of type 2 diabetes and aging?
por: Chang, Yi‐Cheng, et al.
Publicado: (2021) -
Cognitive impairment and its association with circulating biomarkers in patients with acute decompensated heart failure
por: Tung, Ying-Chang, et al.
Publicado: (2022) -
Prolonged Induction Activates Cebpα Independent Adipogenesis in NIH/3T3 Cells
por: Shao, Hsiao-Yun, et al.
Publicado: (2013) -
Identifying cut‐off scores for interpretation of the Heart Failure Impact Questionnaire
por: Hsu, Tsui‐Wen, et al.
Publicado: (2018)